X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (78) 78
oncology (76) 76
humans (72) 72
melanoma (70) 70
male (48) 48
melanoma - pathology (46) 46
female (43) 43
middle aged (41) 41
prognosis (39) 39
skin neoplasms - pathology (35) 35
surgery (34) 34
melanoma - surgery (31) 31
sentinel lymph node biopsy (31) 31
cutaneous melanoma (30) 30
metastasis (30) 30
adult (29) 29
aged (29) 29
survival (28) 28
biopsy (26) 26
lymphatic metastasis (23) 23
lymph node excision (22) 22
malignant-melanoma (22) 22
metastatic melanoma (22) 22
neoplasm staging (21) 21
cancer (20) 20
lymph nodes - pathology (19) 19
skin neoplasms - surgery (19) 19
melanoma - mortality (18) 18
metastases (18) 18
follow-up studies (16) 16
lymph nodes (16) 16
skin neoplasms - mortality (16) 16
sentinel node (15) 15
analysis (14) 14
dissection (14) 14
retrospective studies (14) 14
dermatology (13) 13
ipilimumab (13) 13
melanoma - diagnostic imaging (13) 13
melanoma - secondary (13) 13
sentinel lymph node biopsy - methods (13) 13
tumor burden (13) 13
ultrasonography (13) 13
ultrasound (13) 13
aged, 80 and over (12) 12
follow-up (12) 12
hematology, oncology and palliative medicine (12) 12
medicine & public health (12) 12
medicine, research & experimental (12) 12
survival rate (12) 12
adjuvant therapy (11) 11
surgical oncology (11) 11
lymph nodes - diagnostic imaging (10) 10
lymphatic system (10) 10
patients (10) 10
tumors (10) 10
breast-cancer (9) 9
care and treatment (9) 9
diagnosis (9) 9
disease-free survival (9) 9
health aspects (9) 9
immunotherapy (9) 9
lymph nodes - surgery (9) 9
lymph-node (9) 9
melanoma - diagnosis (9) 9
prospective studies (9) 9
young adult (9) 9
adolescent (8) 8
biopsy, fine-needle - methods (8) 8
clinical-relevance (8) 8
medical research (8) 8
melanoma - drug therapy (8) 8
melanomas (8) 8
multicenter (8) 8
criteria (7) 7
improved survival (7) 7
kaplan-meier estimate (7) 7
patient outcomes (7) 7
prognostic-factors (7) 7
risk factors (7) 7
survival analysis (7) 7
american joint committee (6) 6
braf (6) 6
cohort studies (6) 6
lymph-nodes (6) 6
mek inhibition (6) 6
melanoma - therapy (6) 6
neoplasm recurrence, local - pathology (6) 6
neoplasm staging - methods (6) 6
netherlands - epidemiology (6) 6
research (6) 6
sensitivity and specificity (6) 6
sentinel node biopsy (6) 6
skin neoplasms - diagnosis (6) 6
skin neoplasms - therapy (6) 6
toxicity (6) 6
clinical trials (5) 5
cytology (5) 5
early-stage melanoma (5) 5
high-risk (5) 5
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Melanoma research, ISSN 0960-8931, 03/2019, Volume 29, Issue 4, pp. 358 - 364
In resected high-risk melanoma (stage IIB/C-III) the risk of locoregional and/or distant recurrence is substantial and so far adjuvant therapies have been... 
LYMPH-NODE DISSECTION | SURVIVAL | MEDICINE, RESEARCH & EXPERIMENTAL | COMBINED NIVOLUMAB | adjuvant therapy | melanoma | OPEN-LABEL | DERMATOLOGY | INTERFERON-ALPHA | DABRAFENIB PLUS TRAMETINIB | RESECTED STAGE-III | ONCOLOGY | high-risk melanoma | CUTANEOUS MELANOMA | DOUBLE-BLIND | IPILIMUMAB
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2015, Volume 33, Issue 35, pp. 4227 - 4228
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2019, Volume 81, Issue 4, p. 977
Background: Merkel cell carcinoma (MCC) is a rare and potentially lethal skin cancer. MCC is known for its potential rapid growth and its propensity to... 
The Netherlands | treatment | Merkel cell carcinoma | survival | Carcinoma | Oncology, Experimental | Analysis | Mortality | Skin | Research | Health aspects | Skin cancer | Cancer
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2018, Volume 378, Issue 19, pp. 1789 - 1801
A blinded trial involving patients with resected stage III melanoma showed that adjuvant pembrolizumab every 3 weeks for a year was associated with a 1-year... 
HIGH-RISK MELANOMA | SURVIVAL | MEDICINE, GENERAL & INTERNAL | ANTI-PD-1 THERAPY | EORTC 18952 | TUMOR BURDEN | CUTANEOUS MELANOMA | PHASE-3 TRIAL | PEGYLATED INTERFERON-ALPHA-2B | NODE-POSITIVE MELANOMA | IPILIMUMAB | Skin Neoplasms - drug therapy | Humans | Middle Aged | Male | Adjuvants, Immunologic - adverse effects | Skin Neoplasms - mortality | Aged, 80 and over | Adult | Female | Adjuvants, Immunologic - therapeutic use | Skin Neoplasms - surgery | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Survival Rate | Disease-Free Survival | B7-H1 Antigen - antagonists & inhibitors | Melanoma - drug therapy | Intention to Treat Analysis | Quality of Life | Aged | B7-H1 Antigen - analysis | Infusions, Intravenous | Melanoma - surgery | Neoplasm Staging | Melanoma - mortality | Diagnosis | Drug therapy | Patients | Health aspects | Melanoma | Medical research | Lymphatic system | Risk groups | PD-1 protein | Committees | Metastasis | Survival | Skin cancer | Pembrolizumab | Hospitals | Motivation | PD-L1 protein | Myositis | Death | Mutation | Tumors | Cancer | Index Medicus | Abridged Index Medicus | Placebos | Placebos (Medicine) | Adjuvant treatment of cancer | Tractament adjuvant del càncer
Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 2014, Volume 11, Issue 5, pp. 248 - 249
Journal Article
Journal Article
European Journal of Surgical Oncology, ISSN 0748-7983, 06/2019, Volume 45, Issue 6, pp. 1122 - 1123
Journal Article
Journal Article
Nature Medicine, ISSN 1078-8956, 11/2018, Volume 24, Issue 11, pp. 1655 - 1661
Journal Article
Journal Article
International Journal of Cancer, ISSN 0020-7136, 08/2019, Volume 145, Issue 4, pp. 974 - 978
Talimogene laherparepvec (T‐VEC) is a modified herpes simplex virus, type 1 (HSV‐1), which can be administered intralesionally in patients with stage... 
Talimogene Laherparepvec | melanoma | response evaluation | T‐VEC | oncolytic virus | immunotherapy | T-VEC | COLONY-STIMULATING FACTOR | ONCOLOGY | IMPROVED SURVIVAL | Medicine, Experimental | Medical research | Metastasis | Immunotherapy | Melanoma | Evaluation | Signs and symptoms | Toxicity | Medical services | Herpes simplex | Viruses | Disease control | Patients | Metastases | Influenza | Response rates | Oncolysis | Erythema
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 12/2017, Volume 24, Issue S3, pp. 661 - 662
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1245/s10434-017-6230-7 
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | SENTINEL NODES | SURGERY | ONCOLOGY | CUTANEOUS MELANOMA | Usage | Melanoma | Metastasis | Index Medicus
Journal Article
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 8/2016, Volume 23, Issue 8, pp. 2586 - 2595
In open surgery procedures, after temporarily dimming the lights in the operation theatre, the Photo Dynamic Eye (PDE) fluorescence camera has, amongst others,... 
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | SURGERY | SENTINEL NODE BIOPSY | INDOCYANINE GREEN | TRACER | ONCOLOGY | TIME | MULTIMODAL SURGICAL GUIDANCE | IDENTIFICATION | CARCINOMA | CANCER | Fluorescence | Index Medicus | Head and Neck Oncology
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.